PF-Atlas › Clinical Trials › NCT02054156

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis

azithromycin · Phase 3

Registry ID
NCT02054156
Phase
Phase 3
Status
Completed
Drug / intervention
azithromycin
Sponsor
Bonnie Ramsey
Start
2014-06

About this trial

azithromycin is evaluated in NCT02054156, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Bonnie Ramsey. Current status: Completed.

View NCT02054156 on ClinicalTrials.gov →

Explore related

All azithromycin trialsAll IPF trials

Related trials

azithromycin — NCT02173145Azithromycin — NCT01270074Azithromycin — NCT05842681Azithromycin — NCT02960503Azithromycin — NCT02003911Azithromycin — NCT02803944
Medical disclaimer. This page summarizes public trial data for NCT02054156 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.